Algifor Junior
Algifor Junior is a medicine authorised by Swissmedic under authorisation number 56046. The authorisation holder is Verfora SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 July 2004 and the authorisation is valid without a time limit. ATC code M01AE01 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 56046 |
|---|---|
| Name | Algifor Junior |
| Full name | Algifor Junior, Suspension |
| Authorisation holder | Verfora SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AE01 |
| First authorisation | 08 July 2004 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Algifor Junior, Suspension | B | 08 July 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 200 | ml | M01AE01 | 07.10.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Algifor Junior authorised in Switzerland?
Yes. Algifor Junior is authorised by Swissmedic under authorisation number 56046, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Algifor Junior have?
Algifor Junior is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Algifor Junior?
The authorisation holder is Verfora SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.